BISACODYL

BISACODYL was reported 14216 times

BISACODYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOKINETIC DYSARTHRIA 23 0.7667
1 VAGINAL FLATULENCE 189 0.6238
2 APPENDICOLITH 208 0.5375
3 ANTACID THERAPY 67 0.5154
4 SLEEP DISORDER THERAPY 102 0.5152
5 TOTAL LUNG CAPACITY INCREASED 102 0.3750
6 ANALGESIC THERAPY 100 0.3115
7 DRUG THERAPY 96 0.2832
8 CONGENITAL HIATUS HERNIA 61 0.2675
9 MALIGNANT MELANOMA STAGE 0 51 0.2440
10 ANTICOAGULANT THERAPY 64 0.2254
11 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
12 IVTH NERVE PARALYSIS 42 0.1772
13 VICTIM OF CHILD ABUSE 42 0.1673
14 BACTEROIDES INFECTION 41 0.1571
15 CEREBRAL HYPOPERFUSION 73 0.1567
16 EPIDURAL LIPOMATOSIS 53 0.1541
17 CHILD ABUSE 39 0.1506
18 CAPILLARITIS 37 0.1341
19 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
20 SEDATION COMPLICATION 305 0.1194
21 FEMALE GENITAL TRACT FISTULA 200 0.1170
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 108 0.1165
23 TOTAL LUNG CAPACITY ABNORMAL 43 0.1105
24 MULTIPLE DRUG THERAPY 79 0.1048
25 CEREBELLAR STROKE 35 0.0895
26 PULMONARY VASCULITIS 47 0.0874
27 RADICULOPATHY 202 0.0766
28 SPIROMETRY ABNORMAL 45 0.0753
29 MITE ALLERGY 48 0.0733
30 COLONIC PSEUDO-OBSTRUCTION 20 0.0717
31 CREATININE RENAL CLEARANCE DECREASED 285 0.0711
32 PROCTITIS 195 0.0695
33 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
34 CHRONIC SINUSITIS 258 0.0687
35 MACULAR DEGENERATION 789 0.0660
36 HYPERPHOSPHATAEMIA 142 0.0660
37 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 48 0.0655
38 LEUKOPLAKIA 15 0.0612
39 BLOOD PHOSPHORUS INCREASED 158 0.0578
40 MYCOTIC ALLERGY 48 0.0561
41 TOTAL LUNG CAPACITY DECREASED 86 0.0538
42 HYPOMANIA 185 0.0503
43 JAUNDICE CHOLESTATIC 176 0.0498
44 DUST ALLERGY 48 0.0489
45 PNEUMOCOCCAL INFECTION 24 0.0405
46 PLEURITIC PAIN 96 0.0347
47 CONJUNCTIVITIS ALLERGIC 51 0.0344
48 NEURITIS 51 0.0330
49 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
50 OROMANDIBULAR DYSTONIA 24 0.0329
51 LUNG OPACITY 86 0.0326
52 RESPIRATORY SYMPTOM 85 0.0299
53 DYSPRAXIA 16 0.0284
54 BLOOD CALCIUM DECREASED 303 0.0269
55 BRONCHIECTASIS 180 0.0267
56 IGA NEPHROPATHY 44 0.0265
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
58 PLICATED TONGUE 12 0.0252
59 RHINITIS ALLERGIC 111 0.0249
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 50 0.0245
61 APPENDICITIS 221 0.0236
62 IRON DEFICIENCY 105 0.0233
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 118 0.0233
64 ORTHOSTATIC HYPOTENSION 401 0.0230
65 JUVENILE IDIOPATHIC ARTHRITIS 55 0.0225
66 BLOOD URIC ACID INCREASED 129 0.0223
67 NASAL POLYPS 107 0.0217
68 SARCOIDOSIS 103 0.0217
69 NEPHROGENIC ANAEMIA 99 0.0214
70 SCHIZOPHRENIA 251 0.0206
71 HYPOPHOSPHATAEMIA 152 0.0205
72 HYPORESPONSIVE TO STIMULI 23 0.0196
73 AORTIC STENOSIS 67 0.0192
74 MYASTHENIA GRAVIS 155 0.0192
75 VENTRICULAR FIBRILLATION 213 0.0192
76 VAGINAL DISCHARGE 191 0.0189
77 NORMOCHROMIC NORMOCYTIC ANAEMIA 56 0.0186
78 HYPERPARATHYROIDISM SECONDARY 45 0.0179
79 ORAL CANDIDIASIS 224 0.0170
80 REDUCED FACIAL EXPRESSION 17 0.0167
81 PARAESTHESIA ORAL 240 0.0166
82 RENAL FUNCTION TEST ABNORMAL 74 0.0159
83 CARDIOGENIC SHOCK 228 0.0159
84 FORCED EXPIRATORY VOLUME DECREASED 45 0.0159
85 HYPOGONADISM 15 0.0148
86 SLOW RESPONSE TO STIMULI 18 0.0139
87 SEDATION 359 0.0137
88 BLOOD CALCIUM INCREASED 119 0.0136
89 CARDIAC MURMUR 115 0.0133
90 EFFUSION 18 0.0132
91 RALES 76 0.0131
92 ASPIRATION 140 0.0128
93 END STAGE RENAL DISEASE 227 0.0124
94 BENIGN PROSTATIC HYPERPLASIA 62 0.0120
95 TROPONIN INCREASED 90 0.0118
96 RESPIRATORY DEPRESSION 136 0.0111
97 BREATH SOUNDS ABNORMAL 54 0.0109
98 REBOUND ACID HYPERSECRETION 33 0.0109
99 OBSTRUCTIVE AIRWAYS DISORDER 118 0.0106
100 PELVIC ABSCESS 12 0.0104
101 ON AND OFF PHENOMENON 57 0.0103
102 PULMONARY ALVEOLAR HAEMORRHAGE 55 0.0098
103 COGNITIVE DISORDER 456 0.0098
104 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
105 MUTISM 14 0.0096
106 TONGUE DRY 13 0.0096
107 MULTIPLE ORGAN DYSFUNCTION SYNDROME 267 0.0094
108 ASCITES 277 0.0094
109 NEUROLOGICAL SYMPTOM 53 0.0093
110 ORAL MUCOSAL EXFOLIATION 14 0.0092
111 NEURALGIA 224 0.0092
112 CHOLELITHIASIS 291 0.0089
113 EXCESSIVE EYE BLINKING 13 0.0088
114 FULL BLOOD COUNT ABNORMAL 93 0.0088
115 HYPERLIPIDAEMIA 104 0.0087
116 DEPRESSED LEVEL OF CONSCIOUSNESS 343 0.0087
117 MICTURITION URGENCY 99 0.0087
118 BLOOD TEST ABNORMAL 120 0.0085
119 HEPATOTOXICITY 186 0.0083
120 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 143 0.0083
121 PRODUCT MONITORING ERROR 12 0.0083
122 BACTERIAL INFECTION 155 0.0083
123 SEBORRHOEIC KERATOSIS 12 0.0083
124 FREQUENT BOWEL MOVEMENTS 222 0.0082
125 CLOSTRIDIUM TEST POSITIVE 18 0.0082
126 ANTICHOLINERGIC SYNDROME 13 0.0082
127 PROCEDURAL PAIN 226 0.0081
128 ARTERIOSCLEROSIS 76 0.0081
129 NEUROGENIC BLADDER 17 0.0080
130 STOMA SITE ERYTHEMA 15 0.0080
131 LUNG NEOPLASM 34 0.0080
132 SPUTUM DISCOLOURED 75 0.0079
133 BLOOD BILIRUBIN INCREASED 213 0.0079
134 CONSTIPATION 1610 0.0074
135 GLOSSITIS 26 0.0073
136 HYPONATRAEMIA 407 0.0072
137 MONOCYTE COUNT INCREASED 26 0.0072
138 LARGE INTESTINAL ULCER 19 0.0070
139 PSYCHOTIC DISORDER 205 0.0069
140 PULMONARY FIBROSIS 133 0.0069
141 ULCER 110 0.0069
142 ATELECTASIS 66 0.0068
143 HYPOXIA 238 0.0068
144 DECUBITUS ULCER 55 0.0067
145 SUBILEUS 14 0.0067
146 FAILURE TO THRIVE 34 0.0065
147 COLITIS 248 0.0065
148 METABOLIC ENCEPHALOPATHY 19 0.0063
149 PULMONARY MASS 94 0.0063
150 GOUT 112 0.0062
151 RECTAL HAEMORRHAGE 268 0.0062
152 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 322 0.0062
153 RENAL FAILURE CHRONIC 47 0.0061
154 STOMA SITE DISCHARGE 16 0.0058
155 LISTLESS 19 0.0058
156 BALANCE DISORDER 497 0.0057
157 UROSEPSIS 53 0.0057
158 HEPARIN-INDUCED THROMBOCYTOPENIA 28 0.0057
159 WOUND COMPLICATION 19 0.0055
160 HOSTILITY 14 0.0055
161 FUNCTIONAL GASTROINTESTINAL DISORDER 19 0.0055
162 TONGUE DISCOLOURATION 24 0.0055
163 CANCER PAIN 14 0.0055
164 FAECALOMA 30 0.0055
165 HYPERCHOLESTEROLAEMIA 52 0.0054
166 MOBILITY DECREASED 386 0.0054
167 HAEMOPTYSIS 149 0.0053
168 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
169 TRANSAMINASES INCREASED 116 0.0052
170 COLITIS ISCHAEMIC 35 0.0052
171 NON-CARDIAC CHEST PAIN 16 0.0051
172 AZOTAEMIA 20 0.0050
173 LIVER FUNCTION TEST INCREASED 107 0.0050
174 BLADDER DISORDER 49 0.0049
175 ILEUS PARALYTIC 22 0.0049
176 DYSCHEZIA 15 0.0049
177 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
178 HAEMATOCHEZIA 265 0.0048
179 CATHETER SITE HAEMORRHAGE 12 0.0048
180 SMALL INTESTINAL OBSTRUCTION 59 0.0048
181 FRUSTRATION TOLERANCE DECREASED 38 0.0047
182 COLITIS ULCERATIVE 210 0.0047
183 AORTIC ARTERIOSCLEROSIS 12 0.0047
184 PRODUCT PRESCRIBING ERROR 111 0.0047
185 VASCULITIS 54 0.0046
186 NOCTURIA 56 0.0046
187 TENDERNESS 48 0.0046
188 CHRONIC KIDNEY DISEASE 349 0.0046
189 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 326 0.0046
190 OBESITY 73 0.0046
191 BLOOD ALBUMIN DECREASED 36 0.0045
192 PNEUMONIA ASPIRATION 111 0.0044
193 SEPSIS 495 0.0044
194 CLUMSINESS 12 0.0044
195 IMMOBILE 19 0.0043
196 FREEZING PHENOMENON 16 0.0043
197 NEUTROPHIL COUNT INCREASED 44 0.0043
198 LUNG CONSOLIDATION 12 0.0043
199 ENDOTRACHEAL INTUBATION 12 0.0043
200 TUBULOINTERSTITIAL NEPHRITIS 80 0.0043
201 GENERAL PHYSICAL HEALTH DETERIORATION 493 0.0043
202 PLEURAL EFFUSION 258 0.0042
203 PROSTATE CANCER METASTATIC 14 0.0042
204 WHEEZING 248 0.0042
205 RENAL TUBULAR NECROSIS 41 0.0042
206 INFUSION RELATED REACTION 277 0.0042
207 BONE LESION 15 0.0042
208 MENTAL STATUS CHANGES 115 0.0041
209 SPINAL STENOSIS 17 0.0041
210 LUMBAR SPINAL STENOSIS 12 0.0041
211 LOCALISED OEDEMA 19 0.0041
212 SPINAL OSTEOARTHRITIS 36 0.0041
213 ABDOMINAL DISTENSION 426 0.0041
214 ACUTE RESPIRATORY FAILURE 77 0.0040
215 FOREIGN BODY 16 0.0040
216 NODULE 52 0.0040
217 PROTEIN TOTAL DECREASED 15 0.0040
218 ECONOMIC PROBLEM 60 0.0040
219 HYPERURICAEMIA 16 0.0039
220 HOSPICE CARE 38 0.0038
221 ANAEMIA 729 0.0038
222 RESPIRATORY RATE DECREASED 12 0.0038
223 IRON DEFICIENCY ANAEMIA 35 0.0038
224 BLOOD CREATININE INCREASED 246 0.0038
225 HYPOVOLAEMIA 22 0.0038
226 FEELING COLD 103 0.0037
227 POSTURE ABNORMAL 12 0.0037
228 NECROTISING FASCIITIS 13 0.0037
229 DIVERTICULUM INTESTINAL 16 0.0037
230 HYPERNATRAEMIA 18 0.0036
231 JOINT INJURY 77 0.0036
232 HYPOTENSION 722 0.0036
233 FAECES HARD 14 0.0036
234 ANXIETY DISORDER 12 0.0036
235 MUSCLE SPASTICITY 44 0.0036
236 CORONARY ARTERY DISEASE 108 0.0036
237 DYSARTHRIA 134 0.0036
238 HYPOKALAEMIA 164 0.0035
239 LEUKOCYTOSIS 64 0.0035
240 URINARY RETENTION 118 0.0035
241 PETIT MAL EPILEPSY 18 0.0035
242 ABDOMINAL PAIN 815 0.0035
243 UNRESPONSIVE TO STIMULI 90 0.0035
244 PELVIC FRACTURE 27 0.0035
245 GASTROOESOPHAGEAL REFLUX DISEASE 279 0.0035
246 BLOOD CHOLESTEROL INCREASED 160 0.0034
247 PROCTALGIA 22 0.0034
248 GINGIVAL SWELLING 15 0.0034
249 OEDEMA PERIPHERAL 410 0.0034
250 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
251 HYPOVOLAEMIC SHOCK 16 0.0033
252 SPINAL CORD COMPRESSION 13 0.0033
253 UPPER RESPIRATORY TRACT INFECTION 153 0.0033
254 PRESYNCOPE 80 0.0033
255 THERAPEUTIC PRODUCT EFFECT DELAYED 15 0.0033
256 ABSCESS LIMB 14 0.0033
257 PULMONARY EMBOLISM 306 0.0032
258 MALNUTRITION 36 0.0032
259 LOWER RESPIRATORY TRACT INFECTION 146 0.0032
260 SLEEP DISORDER 226 0.0032
261 HAEMORRHAGIC ANAEMIA 14 0.0032
262 DEMENTIA 89 0.0032
263 ODYNOPHAGIA 19 0.0032
264 CATHETER SITE INFECTION 12 0.0032
265 DYSPEPSIA 309 0.0031
266 ENCEPHALOPATHY 77 0.0031
267 BOWEL MOVEMENT IRREGULARITY 24 0.0031
268 INCONTINENCE 33 0.0031
269 GINGIVAL DISORDER 12 0.0031
270 ANAL INCONTINENCE 28 0.0031
271 DELIRIUM 108 0.0031
272 PERIPHERAL VASCULAR DISORDER 16 0.0031
273 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
274 ACUTE KIDNEY INJURY 468 0.0031
275 RESPIRATION ABNORMAL 21 0.0030
276 THROMBOSIS 245 0.0030
277 CEREBRAL ATROPHY 12 0.0030
278 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 51 0.0030
279 FLUID INTAKE REDUCED 15 0.0030
280 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
281 GRANULOCYTOPENIA 17 0.0030
282 HEPATIC ENZYME INCREASED 203 0.0030
283 HYPOPHAGIA 76 0.0030
284 PNEUMONIA BACTERIAL 27 0.0029
285 PERIPHERAL ISCHAEMIA 12 0.0029
286 HAEMATOCRIT DECREASED 58 0.0029
287 CLOSTRIDIUM DIFFICILE COLITIS 31 0.0029
288 CACHEXIA 15 0.0029
289 DRUG DIVERSION 18 0.0029
290 SCOLIOSIS 18 0.0029
291 TRISMUS 15 0.0029
292 POLYP 19 0.0029
293 TRICUSPID VALVE INCOMPETENCE 23 0.0029
294 INTENTIONAL PRODUCT MISUSE 253 0.0029
295 ATRIAL FLUTTER 23 0.0029
296 INTERNATIONAL NORMALISED RATIO INCREASED 82 0.0029
297 WEIGHT FLUCTUATION 30 0.0029
298 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
299 MUSCLE RIGIDITY 34 0.0028
300 OSTEOPENIA 43 0.0028
301 HYPERVOLAEMIA 14 0.0028
302 LUNG INFILTRATION 25 0.0028
303 HYPOALBUMINAEMIA 22 0.0028
304 HYPOTHYROIDISM 90 0.0028
305 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
306 TEARFULNESS 12 0.0028
307 RENAL FAILURE 369 0.0028
308 HEPATIC LESION 12 0.0028
309 GINGIVAL PAIN 22 0.0028
310 FEBRILE NEUTROPENIA 183 0.0028
311 QUALITY OF LIFE DECREASED 37 0.0028
312 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
313 HYPOKINESIA 40 0.0028
314 GROIN PAIN 24 0.0027
315 ORAL DISORDER 20 0.0027
316 HAEMORRHOIDS 53 0.0027
317 IMPAIRED GASTRIC EMPTYING 37 0.0027
318 BRADYKINESIA 16 0.0027
319 TOXICITY TO VARIOUS AGENTS 455 0.0027
320 ENTEROCOCCAL INFECTION 13 0.0027
321 APLASTIC ANAEMIA 14 0.0027
322 DIABETES MELLITUS 204 0.0027
323 FALL 882 0.0026
324 DRY MOUTH 215 0.0026
325 PNEUMONIA 853 0.0026
326 URINARY INCONTINENCE 78 0.0026
327 DRUG ABUSE 218 0.0026
328 RENAL FAILURE ACUTE 111 0.0026
329 TUMOUR LYSIS SYNDROME 23 0.0026
330 COMPRESSION FRACTURE 14 0.0026
331 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
332 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
333 NEPHROPATHY 24 0.0026
334 METASTASES TO BONE 42 0.0026
335 HICCUPS 21 0.0026
336 BLOOD PROLACTIN INCREASED 12 0.0025
337 SPINAL COMPRESSION FRACTURE 21 0.0025
338 GENERAL SYMPTOM 19 0.0025
339 ENDOCARDITIS 13 0.0025
340 DIVERTICULUM 18 0.0025
341 LUNG NEOPLASM MALIGNANT 104 0.0025
342 PROTHROMBIN TIME PROLONGED 15 0.0025
343 TACHYPNOEA 34 0.0025
344 ILEUS 31 0.0025
345 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
346 MITRAL VALVE INCOMPETENCE 28 0.0025
347 ANHEDONIA 65 0.0025
348 PRODUCTIVE COUGH 118 0.0025
349 BLOOD LACTIC ACID INCREASED 13 0.0025
350 RENAL INJURY 73 0.0025
351 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
352 MOUTH HAEMORRHAGE 18 0.0025
353 FLANK PAIN 23 0.0025
354 LARGE INTESTINE PERFORATION 17 0.0024
355 HYPOMAGNESAEMIA 34 0.0024
356 RESPIRATORY FAILURE 178 0.0024
357 DIABETIC NEUROPATHY 12 0.0024
358 URINARY TRACT INFECTION 412 0.0024
359 LUNG DISORDER 118 0.0024
360 GASTRITIS 63 0.0024
361 CYTOKINE RELEASE SYNDROME 48 0.0024
362 SKIN LACERATION 26 0.0024
363 BLOOD SODIUM DECREASED 45 0.0024
364 PATHOLOGICAL FRACTURE 12 0.0024
365 SENSORY LOSS 19 0.0024
366 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
367 ASPARTATE AMINOTRANSFERASE INCREASED 124 0.0023
368 SWELLING 218 0.0023
369 HAEMATEMESIS 59 0.0023
370 ELECTROLYTE IMBALANCE 27 0.0023
371 MYOPATHY 20 0.0023
372 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
373 PYREXIA 796 0.0023
374 SEPTIC SHOCK 100 0.0023
375 SPEECH DISORDER 120 0.0023
376 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 110 0.0023
377 RIB FRACTURE 47 0.0023
378 INTESTINAL OBSTRUCTION 86 0.0023
379 VOMITING 1071 0.0023
380 CARDIOMEGALY 28 0.0023
381 BLOOD LACTATE DEHYDROGENASE INCREASED 36 0.0023
382 HYDRONEPHROSIS 17 0.0023
383 BLOOD UREA INCREASED 38 0.0023
384 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
385 RENAL CYST 18 0.0023
386 LYMPHOCYTE COUNT DECREASED 40 0.0023
387 CHOLANGITIS 14 0.0023
388 CARDIOVASCULAR DISORDER 57 0.0022
389 INTESTINAL PERFORATION 25 0.0022
390 ECCHYMOSIS 15 0.0022
391 AFFECT LABILITY 21 0.0022
392 INTESTINAL ISCHAEMIA 12 0.0022
393 URINE OUTPUT DECREASED 19 0.0022
394 TORSADE DE POINTES 17 0.0022
395 SUBDURAL HAEMATOMA 31 0.0022
396 HEMIPLEGIA 18 0.0022
397 CELLULITIS 109 0.0022
398 DIPLOPIA 56 0.0022
399 MUSCULOSKELETAL STIFFNESS 188 0.0021
400 PNEUMOTHORAX 34 0.0021
401 DRUG INTERACTION 340 0.0021
402 DEVICE OCCLUSION 30 0.0021
403 COVID-19 PNEUMONIA 25 0.0021
404 HEAD INJURY 67 0.0021
405 CONDITION AGGRAVATED 641 0.0021
406 BACTERAEMIA 25 0.0021
407 HAEMATURIA 72 0.0021
408 NEUTROPENIC SEPSIS 15 0.0021
409 DEHYDRATION 280 0.0021
410 TERMINAL STATE 14 0.0021
411 DYSPHONIA 122 0.0021
412 HERPES VIRUS INFECTION 12 0.0021
413 PRE-EXISTING CONDITION IMPROVED 13 0.0021
414 HYPERKALAEMIA 73 0.0021
415 ABNORMAL FAECES 17 0.0021
416 ANORECTAL DISCOMFORT 11 0.0021
417 SOMNOLENCE 415 0.0021
418 OXYGEN SATURATION DECREASED 115 0.0020
419 POOR QUALITY SLEEP 44 0.0020
420 TACHYCARDIA 181 0.0020
421 RESPIRATORY RATE INCREASED 18 0.0020
422 HYPERCALCAEMIA 25 0.0020
423 HIP FRACTURE 65 0.0020
424 DRUG INTOLERANCE 194 0.0020
425 SENSORY DISTURBANCE 32 0.0020
426 DYSKINESIA 81 0.0020
427 RESPIRATORY DISTRESS 55 0.0020
428 PULMONARY OEDEMA 89 0.0020
429 STEVENS-JOHNSON SYNDROME 44 0.0020
430 BEDRIDDEN 26 0.0020
431 ASTHMA 222 0.0020
432 BLOOD POTASSIUM DECREASED 59 0.0020
433 ESCHERICHIA INFECTION 16 0.0019
434 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
435 CONCUSSION 15 0.0019
436 CARDIO-RESPIRATORY ARREST 81 0.0019
437 WEIGHT DECREASED 540 0.0019
438 MYOCLONUS 23 0.0019
439 POSTOPERATIVE WOUND INFECTION 13 0.0019
440 HAEMOGLOBIN DECREASED 196 0.0019
441 SPINAL DISORDER 18 0.0019
442 PAIN 1167 0.0019
443 LETHARGY 109 0.0019
444 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
445 TREMOR 313 0.0019
446 BRADYCARDIA 100 0.0019
447 JOINT EFFUSION 13 0.0019
448 CYSTITIS 60 0.0019
449 LARGE INTESTINE POLYP 13 0.0019
450 MUSCULOSKELETAL CHEST PAIN 29 0.0019
451 HAEMORRHAGE INTRACRANIAL 28 0.0019
452 AUTOIMMUNE HEPATITIS 13 0.0019
453 TOOTH ABSCESS 19 0.0019
454 BONE DISORDER 34 0.0019
455 SUBARACHNOID HAEMORRHAGE 19 0.0019
456 APHONIA 26 0.0019
457 NAUSEA 1469 0.0019
458 RIGHT VENTRICULAR FAILURE 13 0.0019
459 HIATUS HERNIA 24 0.0019
460 HEPATITIS ACUTE 12 0.0018
461 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
462 CARDIAC ARREST 151 0.0018
463 LIPASE INCREASED 14 0.0018
464 RED BLOOD CELL COUNT DECREASED 52 0.0018
465 TRANSFUSION 19 0.0018
466 LACERATION 17 0.0018
467 CARDIAC FAILURE ACUTE 12 0.0018
468 EOSINOPHIL COUNT INCREASED 15 0.0018
469 BRAIN INJURY 18 0.0018
470 SWOLLEN TONGUE 56 0.0018
471 GASTRIC ULCER 34 0.0018
472 INFUSION SITE ERYTHEMA 15 0.0018
473 MAJOR DEPRESSION 13 0.0018
474 ASTHENIA 666 0.0018
475 ACUTE MYOCARDIAL INFARCTION 52 0.0018
476 DIALYSIS 25 0.0018
477 GAMMA-GLUTAMYLTRANSFERASE INCREASED 39 0.0018
478 GASTROINTESTINAL HAEMORRHAGE 147 0.0018
479 MUCOSAL INFLAMMATION 46 0.0018
480 CONFUSIONAL STATE 283 0.0017
481 OSTEOARTHRITIS 74 0.0017
482 MIOSIS 14 0.0017
483 SKIN ULCER 45 0.0017
484 DEEP VEIN THROMBOSIS 113 0.0017
485 WOUND INFECTION 19 0.0017
486 DYSPHAGIA 163 0.0017
487 MASS 24 0.0017
488 ACIDOSIS 13 0.0017
489 SALIVARY HYPERSECRETION 17 0.0017
490 ORAL PAIN 38 0.0017
491 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
492 LIMB INJURY 46 0.0017
493 PLASMA CELL MYELOMA 66 0.0017
494 HYPOCALCAEMIA 32 0.0017
495 DEVICE RELATED INFECTION 26 0.0017
496 HALLUCINATION 127 0.0017
497 LIVER FUNCTION TEST ABNORMAL 49 0.0017
498 ATRIAL FIBRILLATION 164 0.0017
499 FACIAL PAIN 15 0.0017
500 PULMONARY HYPERTENSION 35 0.0017
501 SEIZURE 194 0.0017
502 OSTEOPOROSIS 69 0.0017
503 PARALYSIS 24 0.0017
504 APNOEA 13 0.0017
505 SEROTONIN SYNDROME 32 0.0017
506 HALLUCINATION, VISUAL 35 0.0017
507 FLATULENCE 94 0.0017
508 OSTEOMYELITIS 30 0.0017
509 RHABDOMYOLYSIS 69 0.0017
510 METASTASES TO LIVER 29 0.0016
511 EATING DISORDER 35 0.0016
512 CARDIAC FAILURE CONGESTIVE 132 0.0016
513 PSEUDOMONAS INFECTION 14 0.0016
514 PETECHIAE 17 0.0016
515 FAECES DISCOLOURED 35 0.0016
516 RHINITIS 13 0.0016
517 JOINT DISLOCATION 17 0.0016
518 SKIN LESION 44 0.0016
519 PRODUCT USE IN UNAPPROVED INDICATION 396 0.0016
520 EAR PAIN 31 0.0016
521 HEMIPARESIS 27 0.0016
522 PULMONARY CONGESTION 21 0.0016
523 OEDEMA 86 0.0016
524 IRRITABLE BOWEL SYNDROME 34 0.0016
525 CIRCULATORY COLLAPSE 27 0.0016
526 COORDINATION ABNORMAL 22 0.0016
527 APATHY 23 0.0016
528 HYPERTENSION 334 0.0016
529 RESPIRATORY TRACT INFECTION 41 0.0016
530 MYOCARDITIS 18 0.0016
531 DYSPNOEA 889 0.0016
532 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
533 DISORIENTATION 62 0.0016
534 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
535 PANCREATITIS ACUTE 35 0.0016
536 ELECTROCARDIOGRAM QT PROLONGED 56 0.0016
537 LYMPHADENOPATHY 55 0.0016
538 SINUS BRADYCARDIA 15 0.0016
539 GASTROENTERITIS VIRAL 28 0.0015
540 SINUS TACHYCARDIA 22 0.0015
541 HAEMODIALYSIS 13 0.0015
542 STAPHYLOCOCCAL INFECTION 51 0.0015
543 MELAENA 34 0.0015
544 VITAMIN D DEFICIENCY 15 0.0015
545 LIVER DISORDER 68 0.0015
546 EXOSTOSIS 14 0.0015
547 GASTROINTESTINAL INFLAMMATION 12 0.0015
548 MUSCULAR WEAKNESS 173 0.0015
549 INCREASED TENDENCY TO BRUISE 14 0.0015
550 FLUID OVERLOAD 22 0.0015
551 CHOLECYSTITIS 18 0.0015
552 ANURIA 13 0.0015
553 PERSONALITY CHANGE 14 0.0015
554 PNEUMONITIS 41 0.0015
555 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
556 FEMUR FRACTURE 46 0.0015
557 PANCYTOPENIA 83 0.0015
558 DECREASED APPETITE 344 0.0015
559 METASTASES TO CENTRAL NERVOUS SYSTEM 19 0.0015
560 PERICARDIAL EFFUSION 34 0.0015
561 DYSURIA 54 0.0015
562 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
563 THROMBOCYTOPENIA 163 0.0015
564 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
565 GASTROINTESTINAL PAIN 16 0.0015
566 TEMPERATURE INTOLERANCE 15 0.0015
567 TOOTH FRACTURE 16 0.0014
568 STOMATITIS 88 0.0014
569 ERYTHEMA 298 0.0014
570 ABDOMINAL PAIN UPPER 298 0.0014
571 EMBOLISM 12 0.0014
572 COAGULOPATHY 24 0.0014
573 GASTROENTERITIS 21 0.0014
574 PHARYNGEAL SWELLING 14 0.0014
575 HYPERGLYCAEMIA 52 0.0014
576 BRAIN OEDEMA 18 0.0014
577 FOOT FRACTURE 27 0.0014
578 MOUTH ULCERATION 30 0.0014
579 TARDIVE DYSKINESIA 40 0.0014
580 SUDDEN DEATH 15 0.0014
581 DELUSION 22 0.0014
582 LUNG INFECTION 22 0.0014
583 EJECTION FRACTION DECREASED 22 0.0014
584 FACIAL PARALYSIS 12 0.0014
585 DYSPNOEA EXERTIONAL 53 0.0014
586 DYSSTASIA 41 0.0014
587 HYPOGLYCAEMIA 68 0.0014
588 METASTASES TO LUNG 16 0.0014
589 PERIPHERAL COLDNESS 19 0.0014
590 TOOTHACHE 25 0.0014
591 ABSCESS 22 0.0014
592 FRACTURE 26 0.0014
593 BLOOD DISORDER 11 0.0014
594 HEART RATE IRREGULAR 31 0.0014
595 BLOOD URINE PRESENT 26 0.0014
596 TOOTH INFECTION 18 0.0014
597 OFF LABEL USE 1194 0.0014
598 COLD SWEAT 24 0.0014
599 MENTAL IMPAIRMENT 33 0.0014
600 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
601 PURPURA 12 0.0014
602 PERITONITIS 28 0.0014
603 HYPERTENSIVE CRISIS 15 0.0013
604 ACUTE MYELOID LEUKAEMIA 21 0.0013
605 C-REACTIVE PROTEIN INCREASED 49 0.0013
606 HEPATIC STEATOSIS 25 0.0013
607 DIZZINESS POSTURAL 13 0.0013
608 SYNCOPE 134 0.0013
609 PARANOIA 23 0.0013
610 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
611 CHOKING 26 0.0013
612 FEEDING DISORDER 27 0.0013
613 LIP DRY 12 0.0013
614 ALANINE AMINOTRANSFERASE INCREASED 81 0.0013
615 PATHOGEN RESISTANCE 12 0.0013
616 PLATELET COUNT DECREASED 140 0.0013
617 ABNORMAL BEHAVIOUR 52 0.0013
618 SLEEP APNOEA SYNDROME 25 0.0013
619 PLATELET COUNT INCREASED 17 0.0013
620 LOWER LIMB FRACTURE 25 0.0013
621 NEUTROPHIL COUNT DECREASED 53 0.0013
622 HEPATIC FAILURE 39 0.0013
623 NEUROPATHY PERIPHERAL 123 0.0013
624 HUNGER 18 0.0013
625 APHASIA 39 0.0013
626 LIP SWELLING 43 0.0013
627 GAIT DISTURBANCE 247 0.0013
628 GALLBLADDER DISORDER 23 0.0013
629 MALAISE 564 0.0013
630 CARDIOMYOPATHY 19 0.0013
631 RESTLESSNESS 47 0.0013
632 BACK PAIN 298 0.0013
633 BLISTER 72 0.0013
634 SKIN HAEMORRHAGE 19 0.0013
635 OESOPHAGITIS 14 0.0013
636 HYPERHIDROSIS 165 0.0013
637 SPLENOMEGALY 15 0.0013
638 SPINAL PAIN 15 0.0013
639 NIGHT SWEATS 41 0.0013
640 CYANOSIS 20 0.0013
641 RESTLESS LEGS SYNDROME 23 0.0013
642 CARDIAC FAILURE 101 0.0013
643 EOSINOPHILIA 22 0.0013
644 CHILLS 147 0.0013
645 VENTRICULAR EXTRASYSTOLES 13 0.0013
646 METABOLIC ACIDOSIS 40 0.0012
647 SKIN INFECTION 14 0.0012
648 TYPE 2 DIABETES MELLITUS 42 0.0012
649 POLLAKIURIA 52 0.0012
650 STATUS EPILEPTICUS 14 0.0012
651 BURSITIS 15 0.0012
652 CHEST PAIN 227 0.0012
653 NEPHROLITHIASIS 56 0.0012
654 GASTROINTESTINAL DISORDER 109 0.0012
655 BONE DENSITY DECREASED 38 0.0012
656 OSTEONECROSIS OF JAW 30 0.0012
657 GENERALISED OEDEMA 15 0.0012
658 BREAST CANCER METASTATIC 13 0.0012
659 AGEUSIA 30 0.0012
660 SEASONAL ALLERGY 17 0.0012
661 AMNESIA 78 0.0012
662 POST PROCEDURAL COMPLICATION 23 0.0012
663 BONE LOSS 18 0.0012
664 CHROMATURIA 27 0.0012
665 SEXUAL DYSFUNCTION 14 0.0012
666 JOINT RANGE OF MOTION DECREASED 16 0.0012
667 EMPHYSEMA 12 0.0012
668 ANGINA PECTORIS 34 0.0012
669 NEUTROPENIA 161 0.0012
670 MOTOR DYSFUNCTION 12 0.0012
671 ISCHAEMIC STROKE 21 0.0012
672 DENTAL CARIES 13 0.0012
673 LACTIC ACIDOSIS 38 0.0012
674 BLOOD POTASSIUM INCREASED 19 0.0012
675 SCAR 20 0.0012
676 BLOOD PRESSURE DECREASED 77 0.0012
677 NO THERAPEUTIC RESPONSE 14 0.0011
678 DRUG LEVEL INCREASED 19 0.0011
679 CEREBRAL HAEMORRHAGE 41 0.0011
680 AGITATION 84 0.0011
681 CYTOPENIA 14 0.0011
682 CONTUSION 110 0.0011
683 MALIGNANT NEOPLASM PROGRESSION 117 0.0011
684 MYOCARDIAL ISCHAEMIA 13 0.0011
685 IMMUNODEFICIENCY 17 0.0011
686 HEADACHE 710 0.0011
687 VERTIGO 69 0.0011
688 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
689 MUSCLE TWITCHING 26 0.0011
690 BODY TEMPERATURE INCREASED 23 0.0011
691 TOOTH EXTRACTION 14 0.0011
692 RESPIRATORY ARREST 31 0.0011
693 ANXIETY 319 0.0011
694 FLUID RETENTION 57 0.0011
695 POISONING 14 0.0011
696 COVID-19 195 0.0011
697 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
698 COUGH 311 0.0011
699 WHITE BLOOD CELL COUNT DECREASED 120 0.0011
700 MULTI-ORGAN FAILURE 19 0.0011
701 ANKLE FRACTURE 17 0.0011
702 SPINAL FRACTURE 22 0.0011
703 RENAL IMPAIRMENT 92 0.0011
704 BRONCHITIS 81 0.0011
705 MANIA 18 0.0011
706 KNEE ARTHROPLASTY 23 0.0011
707 FULL BLOOD COUNT DECREASED 22 0.0011
708 SHOCK 25 0.0011
709 DRUG INEFFECTIVE 1432 0.0011
710 LOSS OF CONSCIOUSNESS 139 0.0011
711 EPISTAXIS 81 0.0011
712 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
713 ORAL HERPES 21 0.0011
714 NECK PAIN 60 0.0011
715 ADRENAL INSUFFICIENCY 13 0.0011
716 CANDIDA INFECTION 18 0.0011
717 FATIGUE 828 0.0011
718 THIRST 19 0.0011
719 PAIN IN EXTREMITY 313 0.0011
720 TOOTH LOSS 22 0.0011
721 DEPRESSION 241 0.0011
722 PAIN IN JAW 30 0.0011
723 RENAL DISORDER 49 0.0011
724 DISTURBANCE IN ATTENTION 56 0.0010
725 TOOTH DISORDER 23 0.0010
726 TENDONITIS 16 0.0010
727 POST PROCEDURAL HAEMORRHAGE 12 0.0010
728 VENTRICULAR TACHYCARDIA 17 0.0010
729 DIARRHOEA 663 0.0010
730 RASH PAPULAR 23 0.0010
731 DRUG DEPENDENCE 165 0.0010
732 HEART RATE DECREASED 36 0.0010
733 SKIN DISCOLOURATION 47 0.0010
734 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
735 GAIT INABILITY 34 0.0010
736 HEAD DISCOMFORT 18 0.0010
737 MUSCLE SPASMS 186 0.0010
738 PERIPHERAL SWELLING 156 0.0010
739 ATAXIA 12 0.0010
740 EXTRAPYRAMIDAL DISORDER 25 0.0010
741 HAEMATOMA 26 0.0010
742 POLYNEUROPATHY 12 0.0010
743 EYE PAIN 56 0.0010
744 ARRHYTHMIA 47 0.0010
745 INSOMNIA 262 0.0010
746 HOSPITALISATION 151 0.0010
747 BRONCHOSPASM 14 0.0010
748 INSURANCE ISSUE 15 0.0010
749 LIVER INJURY 24 0.0010
750 MUSCULOSKELETAL PAIN 51 0.0010
751 OROPHARYNGEAL PAIN 90 0.0010
752 MEDICATION ERROR 54 0.0010
753 MALIGNANT MELANOMA 13 0.0010
754 CONJUNCTIVITIS 18 0.0010
755 DEATH 828 0.0010
756 HEART RATE INCREASED 95 0.0010
757 BLOOD PRESSURE FLUCTUATION 23 0.0010
758 DRUG TOXICITY 13 0.0010
759 CEREBRAL INFARCTION 23 0.0009
760 SCIATICA 15 0.0009
761 LEUKOPENIA 47 0.0009
762 HEPATIC FUNCTION ABNORMAL 35 0.0009
763 GLAUCOMA 18 0.0009
764 MOVEMENT DISORDER 30 0.0009
765 DISCOMFORT 57 0.0009
766 INFUSION SITE PAIN 12 0.0009
767 DYSTONIA 18 0.0009
768 BLOOD IRON DECREASED 11 0.0009
769 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
770 SWELLING FACE 60 0.0009
771 INFECTION 133 0.0009
772 PALLOR 25 0.0009
773 DIZZINESS 456 0.0009
774 LOCALISED INFECTION 22 0.0009
775 CONVULSION 52 0.0009
776 ABDOMINAL DISCOMFORT 152 0.0009
777 FIBROMYALGIA 22 0.0009
778 BONE PAIN 53 0.0009
779 HEPATIC CIRRHOSIS 17 0.0009
780 DISEASE PROGRESSION 107 0.0009
781 HYPOAESTHESIA 135 0.0009
782 SKIN DISORDER 30 0.0009
783 MYELODYSPLASTIC SYNDROME 13 0.0009
784 INCREASED APPETITE 17 0.0009
785 FACE OEDEMA 15 0.0009
786 SINUS CONGESTION 12 0.0009
787 PRODUCT USE ISSUE 166 0.0009
788 INJURY 62 0.0009
789 PALPITATIONS 103 0.0009
790 AGGRESSION 44 0.0009
791 MOOD SWINGS 28 0.0009
792 ACUTE HEPATIC FAILURE 12 0.0009
793 SKIN EXFOLIATION 74 0.0009
794 MENTAL DISORDER 38 0.0009
795 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 157 0.0009
796 MEMORY IMPAIRMENT 119 0.0009
797 DIVERTICULITIS 24 0.0009
798 ILLNESS 89 0.0009
799 INTENTIONAL DRUG MISUSE 18 0.0009
800 HYPOACUSIS 37 0.0009
801 THINKING ABNORMAL 16 0.0009
802 ANGER 29 0.0009
803 IMPAIRED HEALING 28 0.0009
804 ABASIA 21 0.0008
805 GLOSSODYNIA 19 0.0008
806 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
807 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
808 PRODUCT DOSE OMISSION ISSUE 248 0.0008
809 CEREBROVASCULAR ACCIDENT 142 0.0008
810 TASTE DISORDER 17 0.0008
811 RASH ERYTHEMATOUS 40 0.0008
812 CHOLESTASIS 16 0.0008
813 DIABETIC KETOACIDOSIS 20 0.0008
814 BLOOD PRESSURE INCREASED 127 0.0008
815 HYPERTHYROIDISM 12 0.0008
816 ERUCTATION 16 0.0008
817 PARAESTHESIA 130 0.0008
818 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
819 SUICIDE ATTEMPT 50 0.0008
820 TREATMENT NONCOMPLIANCE 45 0.0008
821 HALLUCINATION, AUDITORY 13 0.0008
822 MIGRAINE 78 0.0008
823 GASTRIC DISORDER 28 0.0008
824 INFLAMMATION 42 0.0008
825 PANCREATITIS 43 0.0008
826 MUSCULOSKELETAL DISCOMFORT 14 0.0008
827 VIRAL INFECTION 27 0.0008
828 SINUS DISORDER 16 0.0008
829 TINNITUS 37 0.0008
830 RHINORRHOEA 52 0.0008
831 DEAFNESS 21 0.0008
832 PRESCRIBED UNDERDOSE 16 0.0008
833 EMOTIONAL DISTRESS 97 0.0008
834 NASAL CONGESTION 47 0.0008
835 ABNORMAL DREAMS 22 0.0008
836 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
837 MULTIPLE FRACTURES 13 0.0008
838 SKIN CANCER 17 0.0008
839 MUSCULOSKELETAL DISORDER 15 0.0008
840 PRODUCT PRESCRIBING ISSUE 17 0.0008
841 RASH GENERALISED 20 0.0008
842 BLOOD GLUCOSE DECREASED 37 0.0008
843 NERVOUS SYSTEM DISORDER 24 0.0008
844 HYPERSOMNIA 22 0.0008
845 BRAIN FOG 12 0.0008
846 DERMATITIS 16 0.0008
847 INFLUENZA 85 0.0008
848 MYALGIA 129 0.0008
849 VISION BLURRED 104 0.0008
850 RASH PRURITIC 41 0.0008
851 THERAPY NON-RESPONDER 34 0.0008
852 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
853 OVERDOSE 162 0.0008
854 WEIGHT INCREASED 168 0.0007
855 RASH MACULAR 26 0.0007
856 CHEST DISCOMFORT 76 0.0007
857 DRY EYE 37 0.0007
858 CATARACT 44 0.0007
859 RESPIRATORY DISORDER 22 0.0007
860 CARDIAC DISORDER 68 0.0007
861 ARTHRITIS 57 0.0007
862 NIGHTMARE 25 0.0007
863 MYOCARDIAL INFARCTION 126 0.0007
864 EPILEPSY 22 0.0007
865 NEOPLASM PROGRESSION 25 0.0007
866 SKIN FISSURES 14 0.0007
867 MULTIPLE SCLEROSIS RELAPSE 49 0.0007
868 EAR INFECTION 19 0.0007
869 LIMB DISCOMFORT 22 0.0007
870 RETCHING 15 0.0007
871 SINUSITIS 72 0.0007
872 THROAT TIGHTNESS 19 0.0007
873 ANGIOEDEMA 31 0.0007
874 BURNING SENSATION 49 0.0007
875 HERPES ZOSTER 40 0.0007
876 LACRIMATION INCREASED 21 0.0007
877 THERAPY INTERRUPTED 49 0.0007
878 EYE PRURITUS 23 0.0007
879 PROTEINURIA 13 0.0007
880 DEPRESSED MOOD 36 0.0007
881 RASH MACULO-PAPULAR 15 0.0007
882 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
883 ARTHRALGIA 280 0.0007
884 MULTIPLE SCLEROSIS 32 0.0007
885 KIDNEY INFECTION 13 0.0007
886 THERAPY CESSATION 34 0.0007
887 ERECTILE DYSFUNCTION 17 0.0007
888 DRUG RESISTANCE 17 0.0007
889 SUICIDAL IDEATION 60 0.0007
890 IMPAIRED WORK ABILITY 14 0.0007
891 PRURITUS 251 0.0007
892 COMA 31 0.0007
893 UNEVALUABLE EVENT 49 0.0006
894 GYNAECOMASTIA 20 0.0006
895 PRODUCT ADMINISTRATION ERROR 13 0.0006
896 DRUG-INDUCED LIVER INJURY 20 0.0006
897 FEELING HOT 39 0.0006
898 ABDOMINAL PAIN LOWER 16 0.0006
899 INTENTIONAL DOSE OMISSION 18 0.0006
900 FUNGAL INFECTION 21 0.0006
901 HEPATITIS 16 0.0006
902 RASH 272 0.0006
903 DYSGEUSIA 46 0.0006
904 EMOTIONAL DISORDER 19 0.0006
905 LABORATORY TEST ABNORMAL 18 0.0006
906 BLOOD PRESSURE ABNORMAL 12 0.0006
907 ACCIDENTAL OVERDOSE 22 0.0006
908 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
909 HOT FLUSH 45 0.0006
910 ANAPHYLACTIC SHOCK 15 0.0006
911 VISUAL IMPAIRMENT 72 0.0006
912 JOINT SWELLING 70 0.0006
913 PANIC ATTACK 21 0.0006
914 ADVERSE DRUG REACTION 51 0.0006
915 IRRITABILITY 34 0.0006
916 EYE SWELLING 21 0.0006
917 HAEMORRHAGE 59 0.0006
918 THROAT IRRITATION 25 0.0006
919 OSTEONECROSIS 18 0.0005
920 DEVICE DISLOCATION 23 0.0005
921 SURGERY 31 0.0005
922 BLOOD GLUCOSE INCREASED 99 0.0005
923 FEAR 14 0.0005
924 JAUNDICE 14 0.0005
925 NEOPLASM MALIGNANT 34 0.0005
926 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
927 WOUND 14 0.0005
928 URTICARIA 83 0.0005
929 CRYING 18 0.0005
930 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
931 INFLUENZA LIKE ILLNESS 40 0.0005
932 ARTHROPATHY 27 0.0005
933 HYPERSENSITIVITY 90 0.0005
934 FEELING ABNORMAL 116 0.0005
935 PAIN OF SKIN 13 0.0005
936 VISUAL ACUITY REDUCED 16 0.0005
937 ANAPHYLACTIC REACTION 26 0.0005
938 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
939 INTENTIONAL OVERDOSE 30 0.0005
940 DRY SKIN 62 0.0005
941 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
942 PHARMACEUTICAL PRODUCT COMPLAINT 12 0.0005
943 NERVOUSNESS 24 0.0005
944 ROAD TRAFFIC ACCIDENT 19 0.0005
945 NASOPHARYNGITIS 83 0.0004
946 PANCREATIC CARCINOMA 13 0.0004
947 MOOD ALTERED 12 0.0004
948 ILL-DEFINED DISORDER 26 0.0004
949 PRODUCT DOSE OMISSION 27 0.0004
950 INCORRECT DOSE ADMINISTERED 90 0.0004
951 DRUG ADMINISTRATION ERROR 12 0.0004
952 DRUG WITHDRAWAL SYNDROME 34 0.0004
953 FLUSHING 39 0.0004
954 UNDERDOSE 28 0.0004
955 OCULAR HYPERAEMIA 18 0.0004
956 DEVICE ISSUE 34 0.0004
957 ALOPECIA 73 0.0004
958 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
959 EYE IRRITATION 21 0.0004
960 ECZEMA 19 0.0004
961 INTERSTITIAL LUNG DISEASE 17 0.0004
962 THERAPEUTIC RESPONSE DECREASED 21 0.0003
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
964 TREATMENT FAILURE 27 0.0003
965 INJECTION SITE MASS 12 0.0003
966 EXTRA DOSE ADMINISTERED 13 0.0003
967 BLINDNESS 13 0.0003
968 ADVERSE EVENT 29 0.0003
969 NO ADVERSE EVENT 55 0.0003
970 COMPLETED SUICIDE 25 0.0003
971 RHEUMATOID ARTHRITIS 34 0.0003
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 59 0.0003
973 WITHDRAWAL SYNDROME 12 0.0003
974 DRUG DOSE OMISSION 42 0.0003
975 ACNE 19 0.0003
976 INJECTION SITE REACTION 17 0.0002
977 DRUG EFFECT DECREASED 13 0.0002
978 PROSTATE CANCER 19 0.0002
979 PRODUCT QUALITY ISSUE 32 0.0002
980 PRODUCT SUBSTITUTION ISSUE 13 0.0002
981 INJECTION SITE BRUISING 18 0.0002
982 INJECTION SITE PRURITUS 15 0.0002
983 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
984 BREAST CANCER 18 0.0002
985 INJECTION SITE PAIN 53 0.0002
986 DEVICE MALFUNCTION 12 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
988 INJECTION SITE SWELLING 12 0.0002
989 INJECTION SITE ERYTHEMA 19 0.0002
990 PSORIASIS 19 0.0001